Phase II trial of post-remission therapy with HuM195 and cytotoxic chemotherapy for acute promyelocytic leukemia
Phase of Trial: Phase II
Latest Information Update: 03 Feb 2010
At a glance
- Drugs Lintuzumab (Primary) ; Cytarabine; Idarubicin; Tretinoin
- Indications Acute promyelocytic leukaemia
- Focus Therapeutic Use
- 17 Dec 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 10 Sep 2005 New trial record.